European in vitro diagnostics market was estimated at USD 15.29 billion in 2022 and is likely to grow at a CAGR of 5.08% during 2023-2028 to reach USD 20.66 billion in 2028.
In vitro diagnostics encompasses a wide range of tests done on blood or tissue samples from the human body. These tests are vital for detecting diseases or assessing other health conditions and can also be used to monitor patients’ overall health. By providing vital insights, in vitro diagnostic remains one of the significant components of healthcare, contributing to improved patient outcomes.